Sanara MedTech (SMTI) Competitors $37.70 +0.38 (+1.02%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SMTI vs. AORT, ESTA, BLFS, PLSE, BVS, EYE, CBLL, LQDA, AVNS, and FNAShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include Artivion (AORT), Establishment Labs (ESTA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Bioventus (BVS), National Vision (EYE), CeriBell (CBLL), Liquidia (LQDA), Avanos Medical (AVNS), and Paragon 28 (FNA). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Artivion Establishment Labs BioLife Solutions Pulse Biosciences Bioventus National Vision CeriBell Liquidia Avanos Medical Paragon 28 Artivion (NYSE:AORT) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations, media sentiment and community ranking. Does the MarketBeat Community favor AORT or SMTI? Artivion received 4 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 78.57% of users gave Artivion an outperform vote while only 54.55% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformArtivionOutperform Votes2278.57% Underperform Votes621.43% Sanara MedTechOutperform Votes1854.55% Underperform Votes1545.45% Do institutionals & insiders hold more shares of AORT or SMTI? 86.4% of Artivion shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 8.1% of Artivion shares are held by company insiders. Comparatively, 54.1% of Sanara MedTech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is AORT or SMTI more profitable? Artivion has a net margin of -0.22% compared to Sanara MedTech's net margin of -10.71%. Artivion's return on equity of 5.15% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Artivion-0.22% 5.15% 1.91% Sanara MedTech -10.71%-19.86%-10.91% Which has better valuation and earnings, AORT or SMTI? Sanara MedTech has lower revenue, but higher earnings than Artivion. Artivion is trading at a lower price-to-earnings ratio than Sanara MedTech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArtivion$354M3.35-$30.69M-$0.02-1,413.25Sanara MedTech$78.06M4.22-$4.30M-$0.99-38.08 Does the media favor AORT or SMTI? In the previous week, Artivion and Artivion both had 1 articles in the media. Artivion's average media sentiment score of 1.76 beat Sanara MedTech's score of 0.91 indicating that Artivion is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Sanara MedTech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, AORT or SMTI? Artivion has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Do analysts rate AORT or SMTI? Artivion presently has a consensus price target of $31.00, indicating a potential upside of 9.68%. Sanara MedTech has a consensus price target of $44.00, indicating a potential upside of 16.71%. Given Sanara MedTech's higher possible upside, analysts plainly believe Sanara MedTech is more favorable than Artivion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Artivion 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryArtivion beats Sanara MedTech on 11 of the 16 factors compared between the two stocks. Ad WealthPressI hate to say I told you soLast month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…Follow this link right away. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$329.54M$10.30B$5.38B$8.84BDividend YieldN/A1.10%5.13%4.09%P/E Ratio-38.0824.12105.0417.81Price / Sales4.2230.171,235.79158.52Price / CashN/A23.2340.3536.29Price / Book8.364.947.086.50Net Income-$4.30M$182.72M$119.58M$226.22M7 Day Performance8.80%6.33%2.25%4.03%1 Month Performance16.14%-0.07%-2.34%4.92%1 Year Performance16.29%-1.91%33.95%29.30% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech1.0911 of 5 stars$37.70+1.0%$44.00+16.7%+16.3%$329.54M$78.06M-38.0860High Trading VolumeAORTArtivion1.1873 of 5 stars$28.47+1.6%$31.00+8.9%+68.4%$1.19B$354M-1,404.501,500Positive NewsESTAEstablishment Labs2.3357 of 5 stars$42.50-0.3%$60.60+42.6%+71.4%$1.19B$165.15M-16.52960Positive NewsBLFSBioLife Solutions0.9632 of 5 stars$25.32-0.3%$27.50+8.6%+91.7%$1.17B$143.27M-23.95409Insider TradeAnalyst RevisionPLSEPulse Biosciences1.711 of 5 stars$17.10+6.1%N/A+164.3%$1.05B$700,000.000.00140Positive NewsBVSBioventus2.6689 of 5 stars$11.49-0.2%$13.00+13.1%+206.5%$932.41M$512.34M-18.851,200Positive NewsEYENational Vision3.1137 of 5 stars$11.75+1.7%$14.00+19.1%-40.2%$925.31M$2.18B-57.5313,998Positive NewsCBLLCeriBellN/A$25.59+1.4%$31.20+21.9%N/A$916.74M$60.04M0.00N/AQuiet Period ExpirationLQDALiquidia3.7792 of 5 stars$10.42+2.7%$24.00+130.3%+58.5%$881.95M$17.49M-6.2350AVNSAvanos Medical4.0029 of 5 stars$18.46+2.4%N/A-12.9%$848.37M$681.50M54.063,771Analyst RevisionFNAParagon 282.4274 of 5 stars$9.97-4.4%$15.60+56.5%-0.9%$834.69M$216.39M-14.09343,000Insider Trade Related Companies and Tools Related Companies Artivion Competitors Establishment Labs Competitors BioLife Solutions Competitors Pulse Biosciences Competitors Bioventus Competitors National Vision Competitors CeriBell Competitors Liquidia Competitors Avanos Medical Competitors Paragon 28 Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMTI) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMTI Stock Alerts